Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sadao Aoki

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
American Journal of Hematology|June 22, 2019
Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?Shino Fujimoto, Tomoyuki Sakai, Hiroshi Kawabata, et al.
Human Pathology|April 24, 2018
The clinicopathological comparison among nodal cases of idiopathic multicentric Castleman disease with and without TAFRO syndromeNozomu Kurose, Chizuru Futatsuya, Ken-Ichi Mizutani, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2017
Peripheral T-cell lymphoma, not otherwise specified: a retrospective single-center analysisTakaharu Suzuki, Keisuke Kawamoto, Suguru Tamura, et al.
International Journal of Hematology|April 30, 2021
Patient's age and D-dimer levels predict the prognosis in patients with TAFRO syndromeHiroshi Kawabata, Shino Fujimoto, Tomoyuki Sakai, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 6, 2010
Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases: a multi-institutional studyYasunori Nakagawa, Kenshi Suzuki, Takayuki Hirose, et al.
International Journal of Hematology|June 1, 2021
Correction to: Patient's age and D‑dimer levels predict the prognosis in patients with TAFRO syndromeHiroshi Kawabata, Shino Fujimoto, Tomoyuki Sakai, et al.
International Journal of Hematology|November 25, 2024
Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit studyTsuyoshi Muta, Yosuke Masamoto, Go Yamamoto, et al.
International Journal of Hematology|April 17, 2016
Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 versionYasufumi Masaki, Hiroshi Kawabata, Kazue Takai, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
American Journal of Hematology|June 22, 2019
Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?Shino Fujimoto, Tomoyuki Sakai, Hiroshi Kawabata, et al.
Human Pathology|April 24, 2018
The clinicopathological comparison among nodal cases of idiopathic multicentric Castleman disease with and without TAFRO syndromeNozomu Kurose, Chizuru Futatsuya, Ken-Ichi Mizutani, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2017
Peripheral T-cell lymphoma, not otherwise specified: a retrospective single-center analysisTakaharu Suzuki, Keisuke Kawamoto, Suguru Tamura, et al.
International Journal of Hematology|April 30, 2021
Patient's age and D-dimer levels predict the prognosis in patients with TAFRO syndromeHiroshi Kawabata, Shino Fujimoto, Tomoyuki Sakai, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 6, 2010
Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases: a multi-institutional studyYasunori Nakagawa, Kenshi Suzuki, Takayuki Hirose, et al.
International Journal of Hematology|June 1, 2021
Correction to: Patient's age and D‑dimer levels predict the prognosis in patients with TAFRO syndromeHiroshi Kawabata, Shino Fujimoto, Tomoyuki Sakai, et al.
International Journal of Hematology|November 25, 2024
Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit studyTsuyoshi Muta, Yosuke Masamoto, Go Yamamoto, et al.
International Journal of Hematology|April 17, 2016
Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 versionYasufumi Masaki, Hiroshi Kawabata, Kazue Takai, et al.
Pageof 6